0001209191-14-042347.txt : 20140618 0001209191-14-042347.hdr.sgml : 20140618 20140618163204 ACCESSION NUMBER: 0001209191-14-042347 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20140618 DATE AS OF CHANGE: 20140618 EFFECTIVENESS DATE: 20140618 FILER: COMPANY DATA: COMPANY CONFORMED NAME: HYPERION THERAPEUTICS INC CENTRAL INDEX KEY: 0001386858 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 611512713 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-219438 FILM NUMBER: 14928400 BUSINESS ADDRESS: STREET 1: 2000 SIERRA POINT PARKWAY STREET 2: SUITE 400 CITY: BRISBANE STATE: CA ZIP: 94005 BUSINESS PHONE: 650-745-7802 MAIL ADDRESS: STREET 1: 2000 SIERRA POINT PARKWAY STREET 2: SUITE 400 CITY: BRISBANE STATE: CA ZIP: 94005 D 1 primary_doc.xml X0707 D LIVE 0001386858 HYPERION THERAPEUTICS INC 2000 Sierra Point Parkway Suite 400 Brisbane CA CALIFORNIA 94005 (650) 745-7802 DELAWARE None None Corporation true Donald J. Santel c/o Hyperion Therapeutics, Inc. 2000 Sierra Point Parkway, Suite 400 Brisbane CA CALIFORNIA 94005 Executive Officer Jeffrey S. Farrow c/o Hyperion Therapeutics, Inc. 2000 Sierra Point Parkway, Suite 400 Brisbane CA CALIFORNIA 94005 Executive Officer Bruce F. Scharschmidt c/o Hyperion Therapeutics, Inc. 2000 Sierra Point Parkway, Suite 400 Brisbane CA CALIFORNIA 94005 Executive Officer Klara A. Dickinson c/o Hyperion Therapeutics, Inc. 2000 Sierra Point Parkway, Suite 400 Brisbane CA CALIFORNIA 94005 Executive Officer Christine A. Nash c/o Hyperion Therapeutics, Inc. 2000 Sierra Point Parkway, Suite 400 Brisbane CA CALIFORNIA 94005 Executive Officer Ashley Gould c/o Hyperion Therapeutics, Inc. 2000 Sierra Point Parkway, Suite 400 Brisbane CA CALIFORNIA 94005 Executive Officer Natalie Holles c/o Hyperion Therapeutics, Inc. 2000 Sierra Point Parkway, Suite 400 Brisbane CA CALIFORNIA 94005 Executive Officer James I. Healy c/o Hyperion Therapeutics, Inc. 2000 Sierra Point Parkway, Suite 400 Brisbane CA CALIFORNIA 94005 Director Bo Jesper Hansen c/o Hyperion Therapeutics, Inc. 2000 Sierra Point Parkway, Suite 400 Brisbane CA CALIFORNIA 94005 Director Jake R. Nunn c/o Hyperion Therapeutics, Inc. 2000 Sierra Point Parkway, Suite 400 Brisbane CA CALIFORNIA 94005 Director Bijan Salehizadeh c/o Hyperion Therapeutics, Inc. 2000 Sierra Point Parkway, Suite 400 Brisbane CA CALIFORNIA 94005 Director Lota S. Zoth c/o Hyperion Therapeutics, Inc. 2000 Sierra Point Parkway, Suite 400 Brisbane CA CALIFORNIA 94005 Director Daniel G. Welch c/o Hyperion Therapeutics, Inc. 2000 Sierra Point Parkway, Suite 400 Brisbane CA CALIFORNIA 94005 Director Pharmaceuticals $25,000,001 - $100,000,000 06b false 2014-06-12 false true true 0 7990674 7990674 0 false 0 0 0 0 false HYPERION THERAPEUTICS INC /s/ Jeffrey S. Farrow Jeffrey S. Farrow Chief Financial Officer 2014-06-17